Commit d2bcbd5a authored by Pinar Alper's avatar Pinar Alper
Browse files

Update P12_Exhibit_1_UL_DISH-8_COVIRNA_01_MS_29.10.2020_CK.json

parent 328e773c
......@@ -3,19 +3,19 @@
"source": "P12_Exhibit_1_UL_DISH-8_COVIRNA_01_MS_29.10.2020_CK.xlsx",
"contacts": [
{
"first_name": "Prof.",
"last_name": "Dr.",
"first_name": "John.",
"last_name": "Doe.",
"role": "Principal_Investigator",
"email": "markus.scholz@imise.uni-leipzig.de",
"email": "john.doe@imise.uni-leipzig.de",
"affiliations": [
"Universit\u00e4t Leipzig"
]
},
{
"first_name": "Birgit",
"last_name": "DRAEGER",
"first_name": "Jane",
"last_name": "Doe",
"role": "Legal_Representative",
"email": "markus.scholz@imise.uni-leipzig.de",
"email": "jane.doe@imise.uni-leipzig.de",
"affiliations": [
"Universit\u00e4t Leipzig"
]
......@@ -24,7 +24,7 @@
"first_name": "Ronal",
"last_name": "SPEER",
"role": "Data_Protection_Officer",
"email": "markus.scholz@imise.uni-leipzig.de",
"email": "alice.white@imise.uni-leipzig.de",
"affiliations": [
"Universit\u00e4t Leipzig"
]
......@@ -164,10 +164,10 @@
"url": "https://www.gesundheitsforschung-bmbf.de/de/provid-klinische-molekulare-und-funktionelle-biomarker-fur-prognose-pathomechanismen-und-11690.php",
"contacts": [
{
"first_name": "Prof.",
"last_name": "Dr.",
"first_name": "Jim",
"last_name": "Doe",
"role": "Principal_Investigator",
"email": "martin.witzenrath@charite.de",
"email": "jim.doe@charite.de",
"affiliations": [
"Charit\u00e9 - Universit\u00e4tsmedizin Berlin"
]
......@@ -182,10 +182,10 @@
"url": "https://www.gesundheitsforschung-bmbf.de/de/provid-klinische-molekulare-und-funktionelle-biomarker-fur-prognose-pathomechanismen-und-11690.php",
"contacts": [
{
"first_name": "Grit",
"last_name": "BARTEN-NEINER",
"first_name": "Jack",
"last_name": "Black",
"role": "Other",
"email": "Barten.Grit@mh-hannover.de",
"email": "jack.black@mh-hannover.de",
"affiliations": [
"MHH Hannover"
]
......@@ -294,4 +294,4 @@
"name": "PROVID_2020_01",
"project": "COVIRNA"
}
]
\ No newline at end of file
]
Supports Markdown
0% or .
You are about to add 0 people to the discussion. Proceed with caution.
Finish editing this message first!
Please register or to comment